AAIC 2025 Abstract
Pharmacological targeting of tau‐induced retrotransposon activation
Trial in peopleInterventions
Abstract
Background: Approximately 40% of the human genome is composed of retrotransposons, virus‐like sequences that are typically silenced at the transcriptional and post‐transcriptional levels.
